End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
21.95 CNY | -1.88% | -6.12% | +18.01% |
11:01am | CR Double-Crane Pharmaceutical's Unit Gets Nod to Market Schizophrenia Drug | MT |
08/05 | CR Double-Crane Pharmaceutical's Unit Gets Nod for Lidocaine Hydrochloride Injection | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+18.01% | 309.52Cr | |
+37.74% | 72TCr | |
+34.54% | 59TCr | |
-2.07% | 37TCr | |
+20.25% | 33TCr | |
+2.99% | 28TCr | |
+16.92% | 24TCr | |
+10.10% | 21TCr | |
-4.38% | 21TCr | |
+7.43% | 17TCr |
- Stock Market
- Equities
- 600062 Stock
- News China Resources Double-Crane Pharmaceutical Co.,Ltd.
- Henan Genuine Biotech Denies Report of COVID-19 Drug Now on Market